Clinical Trials Logo
  1. Home
  2. Central Nervous System Tumor
  3. NCT03981016

Medical and Surgical Management of Patients With Brain Metastases — CEREMET-LR  

Central Nervous System Tumor Clinical Trial

Official title:
"In Population" Study of Medical and Surgical Management of Patients With Brain Metastases

Clinical Trial Summary

The integrated cancer research site (SIRIC) of Montpellier proposes to develop a prospective and regional Clinical Database Project and regional biological collection (blood and tumor samples), which is an expanding data collection designed to contribute to a better understand the patient's management with brain metastases including quality of life and neuropsychological/cognitive aspects.

Clinical Trial Description

Brain metastases (BM) represent the first cause of tumors of the central nervous system. Mortality, morbidity (cognitive disorders, neurological deficits, etc.) and their consequences on the quantity and the quality of life are very high. BM represent a real public health problem. The incidence is increasing related to the ageing of the population and the increase of cancer patient's survival rate. The medico-surgical care has highly evolved (neurosurgical progress, radiosurgery, stereotaxic radiotherapy and new chemo and targeted therapy). Every histological or biological profile requires a specific evaluation, and management. Clinical trials are the reference to establish the efficacy and the toxicity of the new processes, but usually answer only at a single question and for very selected patients. For this reason, the SIRIC Montpellier Cancer proposes to develop a prospective and regional Clinical Database Project and regional biological collection (blood and tumor samples), which is an expanding data collection designed to contribute to a better understand the patient's management with brain metastases including quality of life and neuropsychological/cognitive aspects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03981016
Study type Interventional
Source Institut du Cancer de Montpellier - Val d'Aurelle
Contact
Status Completed
Phase N/A
Start date March 2, 2015
Completion date August 31, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04743310 - Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System Phase 2
Completed NCT02496520 - Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults Phase 1/Phase 2
Recruiting NCT06054295 - Somatic Mosaicism in Twins Discordant for Childhood Cancer
Completed NCT00002594 - Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors Phase 2
Active, not recruiting NCT02932280 - Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment Phase 1/Phase 2
Completed NCT00078988 - High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Phase 3
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT00238264 - Radiation Therapy in Treating Young Patients With Gliomas Phase 2
Completed NCT00006024 - Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Completed NCT00716976 - Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Phase 3
Recruiting NCT05978557 - Brain Slice Explants to Predict Drug Response in Brain Tumors
Recruiting NCT04852354 - Tissue Collection for Drug Screening and Bioanalysis
Completed NCT00077207 - Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma N/A
Completed NCT00085098 - Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor Phase 3
Active, not recruiting NCT03052738 - Medical Marijuana in the Pediatric Central Nervous System Tumor Population
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Terminated NCT04096716 - Mapping Draining Lymph Nodes in CNS Malignancies Phase 1
Recruiting NCT01595126 - Longitudinal Study of Biomarkers N/A
Recruiting NCT04185038 - Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors Phase 1